Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept for Graft Versus Host Disease Prophylaxis
NCT01743131Phase 2Completed
- Sponsor
- Boston Children's Hospital
- Start
- Feb 2013
- Primary completion
- Jun 2018
- Modality
- Fc-Fusion Proteins
- Countries
- 2
01
Overview
A Phase 2 trial of abatacept in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Boston Children's Hospital. Started Feb 2013; status: completed.
02
Drugs
abatacept
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT01743131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01743131.